LAVIPHARM S.A. NA EO 1 (BXA0) — Free Cash Flow Generation Index
LAVIPHARM S.A. NA EO 1 (BXA0) has a Free Cash Flow Generation Index of -1.08x as of December 2024. Free cash flow of €-5.00 Million represents -1% of operating cash flow (€4.64 Million). Explore BXA0 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
LAVIPHARM S.A. NA EO 1 Free Cash Flow Generation Index (2021–2024)
Historical FCF Generation Index trend for LAVIPHARM S.A. NA EO 1 across 4 annual periods. For the full cash flow conversion analysis, see BXA0 cash flow conversion.
Annual Free Cash Flow Generation for LAVIPHARM S.A. NA EO 1 (2021–2024)
Year-by-year Free Cash Flow Generation Index for LAVIPHARM S.A. NA EO 1. Check BXA0 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.08x | €-5.00 Million | €4.64 Million | €9.64 Million | ▲ +91.9% |
| 2023 | -13.26x | €-3.77 Million | €284.00K | €4.05 Million | ▼ -37.5% |
| 2022 | -9.64x | €-32.27 Million | €3.35 Million | €35.62 Million | ▼ -1907.9% |
| 2021 | 0.53x | €2.19 Million | €4.11 Million | €1.92 Million | — |